1. "2023"
Formats
  1. Journal Article (2318)
  2. Meeting Abstract (1954)
  3. Review (629)
  4. Editorial (353)
  5. Book Section (144)
  6. Research Letter (101)
  7. Guidelines (97)
  8. Correspondence (91)
  9. Miscellaneous (57)
  10. Conference Paper (50)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1380)
  3. Sloan Kettering Institute Postdocs (1151)
  4. Hematologic Malignancies, Division of (1038)
  5. GSK Faculty (1016)
  6. Surgery (930)

More Groups

People
  1. Saad Usmani (123)
  2. Sergio Giralt (104)
  3. Miguel-Angel Perales (101)
  4. Gilles Salles (97)
  5. Gunjan Shah (85)
  6. Michael Scordo (81)

More People

Years
  1. 2023 (5804)
Publications
  1. Journal of Clinical Oncology (553)
  2. Blood (402)
  3. Annals of Oncology (154)
  4. Annals of Surgical Oncology (120)
  5. International Journal of Radiation Oncology, Biology, Physics (116)
  6. Laboratory Investigation (88)

More Publications

Publishers
  1. Elsevier Inc. (762)
  2. American Society of Clinical Oncology (606)
  3. American Society of Hematology (478)
  4. Springer (375)
  5. Oxford University Press (359)
  6. Nature Publishing Group (339)

More Publishers

Results (5804)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiopharmaceutical therapy
    Book Whole

    Bodei, L.; Lewis, J. S.; Zeglis, B. M.
    Springer (2023)

    Fulltext@MSK | Save
  • Case study #1: Alpha particle therapy of leukemia using (225)Ac-lintuzumab
    Book Section

    McDevitt, M. R.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Dosimetry in radiopharmaceutical therapy
    Book Section

    Carter, L. M.; Kesner, A. L.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • A brief history of radiopharmaceutical therapy
    Book Section

    Cederquist, G. Y.; Escorcia, F. E.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Case study #2: Disialoganglioside GD2 as a target for radiopharmaceutical therapy
    Book Section

    Cheung, N. K. V.; Kramer, K.; Modak, S.; Kushner, B. H.; Ahmed, M.; Santich, B.; Cheal, S.; Larson, S.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Nivolumab in salivary gland cancers: Confronting the challenges of unlocking the therapeutic benefits of immunotherapy for rare diseases
    Editorial

    Desilets, A.; Ho, A. L.
    BMJ Oncology (2023)

    Fulltext@MSK | Save
  • Esophageal Cancer: Diagnosis and Treatment. 2nd ed
    Book Whole

    Schlottmann, F.; Ferri, L.; Molena, D.; Patti, M. G.
    Springer (2023)

    Fulltext@MSK | Save
  • Dance/movement therapy for infants and young children with medical illness: Treating somatic and psychic distress
    Book Whole

    Tortora, S.; Keren, M.
    Routledge (2023)

    Fulltext@MSK | Save
  • Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates
    Journal Article

    King, D. A.; Smith, A. R.; Pineda, G.; Nakano, M.; Michelini, F.; Goedegebuure, S. P.; Thyparambil, S.; Liao, W. L.; McCormick, A.; Ju, J. H.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Important considerations for real-world analysis of neurotrophic tyrosine receptor kinase fusion cancer and tropomyosin receptor kinase inhibitors
    Correspondence

    Brose, M. S.; Hong, D. S.; Drilon, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save